Robert N. Fried

CIK: 0001417952

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (33.3%)

Derivative conversions

Awards (A)4 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

NAGE

Niagen Bioscience, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

NAGE
Niagen Bioscience, Inc.
Jun 30, 2026
Award(A)
Direct
1.1K shares at avg. $2.71$3K
NAGE
Niagen Bioscience, Inc.
Apr 24, 2026
Exercise(M)
Direct
20K shares at avg. $2.61$52K
NAGE
Niagen Bioscience, Inc.
Feb 19, 2026
Award(A)
Employee Stock Options (right to buy)
Direct
503.9K shares-
NAGE
Niagen Bioscience, Inc.
Apr 9, 2025
Exercise(M)
Direct
66.7K shares at avg. $3.30$220K
CDXC
ChromaDex Corp.
Feb 25, 2025
Award(A)
Performance Stock Unit
Direct
1.5M shares-
CDXC
ChromaDex Corp.
Feb 12, 2025
Award(A)
Employee Stock Options (right to buy)
Direct
492.3K shares-

		Type	Shares	Price		Ownership
Jun 30, 2026	NAGE Niagen Bioscience, Inc.	Award(A)	1,106	$2.71	$2,997	Direct
Apr 24, 2026	NAGE Niagen Bioscience, Inc.	Exercise(M)	20,000	$2.61	$52,200	Direct
Feb 19, 2026	NAGE Niagen Bioscience, Inc.	Award(A) Employee Stock Options (right to buy)	503,937	-	-	Direct
Apr 9, 2025	NAGE Niagen Bioscience, Inc.	Exercise(M)	66,667	$3.30	$220,001	Direct
Feb 25, 2025	CDXC ChromaDex Corp.	Award(A) Performance Stock Unit	1,518,600	-	-	Direct
Feb 12, 2025	CDXC ChromaDex Corp.	Award(A) Employee Stock Options (right to buy)	492,278	-	-	Direct

1-6 of 6 transactions

About Fried Robert N

Fried Robert N (SEC CIK 0001417952) files insider reports with the SEC as Chief Executive Officer of Niagen Bioscience, Inc. (NAGE).

Signal8 holds 6 ownership filings by Fried Robert N, all Form 4s, filed between Feb 14, 2025 and Jul 8, 2026. Those filings report 6 transactions, from Feb 12, 2025 to Jun 30, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Fried Robert N's filings is in LOS ANGELES, CA.

Recent filings by Fried Robert N

Jun 30, 2026: Grant or award of NAGE shares (Form 4, code A).
Apr 24, 2026: Option exercise of NAGE shares (Form 4, code M).
Feb 19, 2026: Grant or award of NAGE derivative securities (Form 4, code A).
Apr 9, 2025: Option exercise of NAGE shares (Form 4, code M).
Feb 25, 2025: Grant or award of CDXC derivative securities (Form 4, code A).

Other insiders filing for Niagen Bioscience, Inc. (NAGE)

Lopez Carlos Luis, SVP, General Counsel
Pamir Ozan, Chief Financial Officer
YU Wing Tak Wendy, Director
Ng Wang Yu Gary, Director
Cohen Ann, Director
Patrick Kristin, Director

How to read Form 4 transaction codes